DETOUR1 Clinical Trial Study: 24-Month Data Presented at VIVA
DETOUR1 Clinical Trial includes a 79% primary patency, with 82% of patients maintaining freedom from major adverse events at 2 years post-procedure.
November 13, 2020
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
View the latest clinical trials, studies, data, and updates.
Append Medical Completes In-Vivo Pre-clinical Chronic Procedures for Stroke Reduction
Append Medical notes the procedures were completed with IMMR, one of the world’s leading preclinical laboratories and paves the way for the first human trial.
November 12, 2020
CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study
The RejuvenAir System received CE mark last year, and this post-market study aims to identify molecular and cellular targets in the central airways of patients before and after MCS treatment to determine the mechanism which enables metered cryospray to rejuvenate damaged airways in Chronic Bronchitis patients.
November 11, 2020
NeuroBlate System Multi-Center Clinical Study Published In Epilepsy Research
November 10, 2020 NeuroBlate System for the treatment of drug resistant epilepsy have been published in the peer-reviewed journal Epilepsy Research. The paper describes data
November 10, 2020
Avess Study: 6-Month Data AV Fistula DCB First-in-Human Study Presented at Viva 2020
AVESS study is a prospective, multi-center, single-arm study to assess the safety and performance of the Avess DCB* when used in the treatment of subjects with obstructive lesions of arteriovenous fistulae (AVF) for hemodialysis.
November 9, 2020
LimFlow System Demonstrates Excellent Sustained Amputation-free Survival and Wound Healing at 1 Year in PROMISE I U.S. Study
LimFlow notes the results were presented in the Late-Breaking Data session at the VIVA Conference by Daniel Clair, MD, PROMISE I principal investigator and chair of the department of surgery at the University of South Carolina (USC) and Prisma Health-USC Medical Group.
November 6, 2020
